Amrutanjan Health Care per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹18.67₹20.03₹17.58₹15.56₹13.65
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹18.67₹20.03₹17.58₹15.56₹13.63
₹128.06₹128.06₹112.97₹99.78₹99.47
₹176.91₹173.83₹156.28₹145.70₹129.87
—₹12.44₹17.61₹9.65₹6.57
−₹6.58−₹6.58₹5.31₹7.33₹3.52
—₹4.57₹4.59₹4.63₹4.60
2.92.92.92.92.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

AMRUTANJAN₹493.00

Amrutanjan Health Care Limited

· Pharma & Health
₹ CrorePeersJAGSNPHARMNGLFINESIGACHILINCOLNSYNCOMFTHEMISMEDHESTERBIOMcap ₹1,425 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS13.6515.5617.5820.0318.67
Diluted EPS13.6315.5617.5820.0318.67
Book Value per Share99.4799.78112.97128.06128.06
Revenue per Share129.87145.70156.28173.83176.91
Cash Flow per Share6.579.6517.6112.44—
Free Cash Flow per Share3.527.335.31-6.58-6.58
Dividends per Share4.604.634.594.57—
Shares Outstanding (cr)2.92.92.92.92.9
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.